Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia (HOMESIDE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03907748 |
|
Recruitment Status :
Recruiting
First Posted : April 9, 2019
Last Update Posted : July 29, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dementia Dementia, Vascular Dementia With Lewy Bodies Dementia, Mixed Dementia Alzheimers Behavioural and Psychiatric Symptoms of Dementia Depression Quality of Life | Other: Music Intervention Other: Reading Intervention | Not Applicable |
This three-arm parallel-group randomised controlled trial will involve 495 couples (cohabiting caregivers and people with dementia) across 5 countries. Caregivers allocated to the music or reading intervention groups will be given three 2-hour training sessions in the allocated intervention. They will be asked to deliver the intervention to the person they are caring for 5x weekly for 3 months. Data will be collected prior to implementing the intervention, during the intervention (via diaries kept by the caregivers), after the last week of implementing the intervention and 3-months after implementing the intervention.
The investigators will explore whether caregiver-delivered music or reading activities improve behavioural and psychological symptoms for people living with dementia. The researchers will also seek to find out the impact on other aspects of both the person with dementia and their caregiver's quality of life and well being. Additionally, costs associated with the care of the person with dementia will be evaluated to determine cost-effectiveness of delivering a music intervention.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 990 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Participants (people with dementia and their cohabiting family caregivers) will be allocated to either (1) the music intervention group, (2) the reading intervention group or (3) the standard care group. |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Outcome measures will be collected by researchers who are not aware of the whether the participants' are allocated to the music, reading or standard care groups. The participants will be reminded not to reveal the group they are in to the person collecting the data. The participants themselves cannot be blinded due to the active nature of the intervention. |
| Primary Purpose: | Supportive Care |
| Official Title: | HOMESIDE: Home-based Family Caregiver-delivered Music and Reading Interventions for People Living With Dementia: A Randomised Controlled Trial |
| Actual Study Start Date : | November 20, 2019 |
| Estimated Primary Completion Date : | April 1, 2022 |
| Estimated Study Completion Date : | April 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Music Intervention
The music intervention will be provided to participant dyads (people with dementia and their cohabiting family caregivers) allocated to the first intervention. Caregivers will be trained to use the music intervention in three 2-hour training sessions with an intervention trainer (a music therapist). Training will take place at the dyad's home. The caregiver will then be asked to deliver the music intervention to the person with dementia at least 5x per week for 30 minutes.
|
Other: Music Intervention
After training, caregivers will deliver the music intervention to the person with dementia whom they care for. The music intervention will include: a) singing familiar/preferred music followed by discussions facilitated by the caregiver about any associated meanings or memories; b) movement to music (e.g. upper body and arms imitating familiar dance movements to music); c) instrument playing; and d) listening to familiar/preferred relaxing or enlivening music (dependent upon symptoms present in the moment). These methods are known to assist in emotion regulation and increase cognitive reserve (e.g. attention and perceptual-motor function). |
|
Active Comparator: Reading Intervention
The reading intervention will be provided to participant dyads (people with dementia and their cohabiting caregivers) allocated to the second intervention. Caregivers will be trained to use the reading intervention in three 2-hour training sessions with an intervention trainer. Training will take place at the dyad's home. The caregiver will then be asked to deliver the reading intervention to the person with dementia at least 5x per week for 30 minutes.
|
Other: Reading Intervention
After training, caregivers will deliver the reading intervention to the person with dementia whom they care for. The reading intervention will include: a) the caregiver reading aloud to the person they are caring for; b) the person with dementia reading aloud to their caregiver; and c) discussion of the text and personal responses. Strategies to engage the person with dementia and to create opportunities for meaningful dialogue will be provided, as well as guidance on selecting reading material that is accessible to the person's level of cognitive impairment. |
|
No Intervention: Standard Care
Participant dyads (people with dementia and their cohabiting caregivers) allocated to the standard care group will not receive any training or be asked to deliver an intervention.
|
- Change from baseline of behavioural and psychological symptoms of participants with dementia at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Neuropsychiatric Inventory Questionnaire (NPI-Q). Severity scores range from 0-36, where higher scores indicate more severe behavioural and psychological symptoms of dementia. Distress scores range from 0-60, where higher values represent higher levels of distress due to symptoms.
- Change from baseline of depression in participants with dementia at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Montgomery Asberg Depression Rating Scale (MADRS). Scale scores range from 0-60, where higher scores indicate more severe depression.
- Change from baseline of quality of life of participants with dementia at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Quality of Life - Alzheimer's Disease (QoL-AD) scale. Scale scores range from 13-52, where higher scores indicate higher quality of life.
- Change from baseline of depression in caregiver participants at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Patient Health Questionnaire-9 (PHQ-9). Scale scores range from 0-27, where scores greater than 20 indicate severe depression.
- Change from baseline of resilience in caregiver participants at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Resilience Scale-14 (RS-14). Scale scores range from 14-98, where higher scores indicate higher resilience.
- Change from baseline in caregiver competence of caregiver participants at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Short Sense of Competence Questionnaire (SSCQ). Scale scores range from 7-35, where higher scores indicate higher sense of competence.
- Change from baseline in quality of life of caregiver participants at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Assessment of Quality of Life-6D (AQOL-6D).
- Change from baseline in quality of the relationship between caregiver and person with dementia at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Quality of Caregiver-Patient Relationship (QCPR). Scale scores range from 14-70, where higher scores indicate a higher quality of relationship.
- Change from baseline in quality of adjusted life-years of caregiver and person with dementia at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the EuroQoL Instrument (EQ-5D-5L).
- Change from baseline in resource use of both caregiver and person with dementia (cost-effectiveness) at post-intervention and 6-month follow-up [ Time Frame: baseline, 12-weeks (primary time-point), and 6-months after intervention commencement (follow-up) ]Measured by the Resource Utilization in Dementia (RUD).
- Intervention dosage throughout intervention [ Time Frame: Throughout the 12-weeks caregiver-delivered intervention (at least 5x per week) ]Measured using the tailored diary for caregivers to record the duration of music or reading intervention use, responses of the person with dementia and details of activities used.
- Caregivers' experiences of delivering the music and reading interventions [ Time Frame: 12-weeks (primary time point) ]Measured using post-intervention qualitative interviews with caregivers to capture descriptions of their experience of delivering the intervention and data to fine-tune the training, research design and the protocol.
- Caregivers' experiences and reactions to the music and reading intervention training sessions [ Time Frame: Post intervention training sessions at 1-week, 3-weeks, and 6-weeks ]Measured using a short questionnaire.
- Caregivers' adherence to programme and ability to apply the learning from the training sessions in their day-to-day caring [ Time Frame: Throughout the 12-weeks caregiver-delivered intervention (at least 5x per week) ]Measured using the tailored diary for caregivers to record the duration of music or reading intervention use, responses of the person with dementia and details of activities used
- Change from baseline of cognition of participants with dementia at post-intervention to explore relationship between cognitive decline, behavioural and psychological symptoms of dementia, depression and response to different conditions [ Time Frame: baseline and 12-weeks (primary time-point, post-intervention) ]Measured using the Mini-Mental State Examination (MMSE). Scores Higher scores indicate better cognitive capacity with scores of 24-30 indicating no cognitive impairment; 19-23 indicating mild cognitive impairment; 10-18 indicating moderate cognitive impairment; and scores <10 indicating severe cognitive impairment.
- Adverse events [ Time Frame: Phone calls at weeks 2, 4, 6, 8, 10, 12 ]Adverse events will be measured throughout the 12-week intervention period for all groups via fortnightly phone calls. Participants will be asked about any adverse events they may have experienced, including hospitalisations, unexpected GP appointments or negative responses to the interventions.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Dyads (cohabiting) who are close in relationship and where one member has a diagnosis of dementia according to ICD-10 criteria (Alzheimer's Disease [AD], Frontotemporal Dementia, Vascular Dementia [VD], Lewy Body Disease, or mixed dementia) as determined by a clinician experienced in diagnosing dementia. Close in relationship refers to a caregiver who may be a sibling, spouse, adult child, friend, niece or nephew or any person who has a close relationship to the person with dementia, that is, anyone who is not a formal paid caregiver.
- Dyads where the person with dementia has a Neuropsychiatric Inventory-Questionnaire (NPI-Q) Score of ≥6 (from a maximum score of 36)
Exclusion Criteria:
- Dyads where either or both the caregiver or person with dementia have significant hearing impairments that are not resolved through the use of a hearing aid device and limit their capacity to enjoy musical experiences
- There will be no further exclusions
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03907748
| Contact: Felicity Baker, Professor | +61402172795 | felicity.baker@unimelb.edu.au | |
| Contact: Helen M Odell-Miller, Professor | 004489451962045 | helen.odell-miller@anglia.ac.uk |
| Australia | |
| The University of Melbourne | Recruiting |
| Melbourne, Australia, 3006 | |
| Contact: Felicity Baker, Professor +61402172795 felicity.baker@unimelb.edu.au | |
| Germany | |
| University of Applied Sciences Würzburg-Schweinfurt | Recruiting |
| Würzburg, Germany, 97070 | |
| Contact: Thomas Wosch, Professor +49 931 3511-0 Thomas.Wosch@fhws.de | |
| Norway | |
| Norwegian Academy of Music | Recruiting |
| Oslo, Norway, 0302 | |
| Contact: Karette Stensaeth, A/Professor +47 94844648 Karette.A.Stensaeth@nmh.no | |
| Poland | |
| University of Physical Education in Krakow | Recruiting |
| Kraków, Poland | |
| Contact: Anna A Bukowska, Dr +48 12 683 10 00 annabookowska@gmail.com | |
| United Kingdom | |
| Anglia Ruskin University | Recruiting |
| Cambridge, Cambridgeshire, United Kingdom, CB1 1PT | |
| Contact: Helen Odell-Miller, Professor 01223698045 helen.odell-miller@anglia.ac.uk | |
| Study Director: | Felicity Baker, Professor | University of Melbourne |
| Responsible Party: | Anglia Ruskin University |
| ClinicalTrials.gov Identifier: | NCT03907748 |
| Other Study ID Numbers: |
U4-10366 ACTRN12618001799246p ( Registry Identifier: Austrailian New Zealand Clinical Trials Registry ) 462 ( Other Grant/Funding Number: Alzheimer's Society ) |
| First Posted: | April 9, 2019 Key Record Dates |
| Last Update Posted: | July 29, 2020 |
| Last Verified: | July 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | In accordance with the Australian Code for Responsible Conduct of Research (Universities Australia, 2018), all data will be retained for retrieval and re-use in future research where participant permission is granted. Data made available will include individual-level deidentified participant data, reports on adverse events, and deidentified interview transcripts. |
| Supporting Materials: |
Study Protocol |
| Time Frame: | Following project completion, de-identified anonymised data will be made available (with participant consent). According to the GDPR, the consortium have agreed for reused for 10 years after the project has been completed. |
| Access Criteria: | Data will be made available on the Australian Data Archive https://ada.edu.au and listed on Research Australia's https://researchaustralia.org website to facilitate access for future research. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
music therapy music interventions home-based interventions |
Reading dementia care giver |
|
Dementia Alzheimer Disease Lewy Body Disease Dementia, Vascular Brain Diseases Central Nervous System Diseases Nervous System Diseases Neurocognitive Disorders Mental Disorders Tauopathies Neurodegenerative Diseases Parkinsonian Disorders |
Basal Ganglia Diseases Movement Disorders Synucleinopathies Cerebrovascular Disorders Intracranial Arteriosclerosis Intracranial Arterial Diseases Leukoencephalopathies Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases |

